Fig. 2From: Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registrya) Overall survival of IPF patients on pirfenidone (full line) and no-antifibrotic treatment (dashed line), b) Reason for end of follow-up of enrolled IPF patientsBack to article page